share_log

Sera Prognostics | 4: Statement of changes in beneficial ownership of securities-Officer Boniface John J.

SEC announcement ·  Mar 26 16:34
Summary by Moomoo AI
John J. Boniface, Chief Scientific Officer of Sera Prognostics, completed a sale of 22,163 shares of the company's common stock on March 25, 2024. The transaction was executed at a price of $9.10 per share, resulting in a total sale value of $201,683.30. Following the sale, Boniface's direct holdings in Sera Prognostics amount to 164,962 shares. The sale took place in an open market or private sale, according to the transaction details provided.
John J. Boniface, Chief Scientific Officer of Sera Prognostics, completed a sale of 22,163 shares of the company's common stock on March 25, 2024. The transaction was executed at a price of $9.10 per share, resulting in a total sale value of $201,683.30. Following the sale, Boniface's direct holdings in Sera Prognostics amount to 164,962 shares. The sale took place in an open market or private sale, according to the transaction details provided.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more